… , and 0.38 % among patients with atrial fibrillation. In conclusion, warfarin treatment where
patients spend a high proportion of time in the therapeutic range is safe and effective, and will …

… 3, randomised trials of patients with atrial fibrillation who were randomised to receive new
oral anticoagulants or warfarin, and trials in which both efficacy and safety outcomes were …

… , the results of this study can provide insights into differences in safety and efficacy outcomes
of warfarin use in thrombocytopenic population compared to normal anticoagulated patients…

… that adjusted-dose warfarin was substantially more efficacious than placebo and … patients
have higher risks of bleeding.14–16 The rate of major bleeding when treated with warfarin …

… the balance between safety and efficacy of the NOACs compared with warfarin. NOACs
demonstrated promising alternatives to warfarin in prevention of stroke in patients with AF. …

… in a comparative manner to warfarin both for chronic … over warfarin, as well as a favorable
efficacy and safety profile being at least noninferior and often superior to warfarin in patients …

… the use of dabigatran versus warfarin in catheter ablation for AF. The main objectives of
this study were: (1) evaluate the efficacy and safety of dabigatran compared to warfarin; (2) …

… in terms of efficacy and safety outcomes with warfarin and … warfarin- and dabigatran-treated
patients, but adjusted mortality was lower with both dabigatran doses compared with warfarin…

… toward both increased efficacy and safety (ie, reduction in bleeding events compared with
warfarin). … the relative efficacy and safety of the NOACs and extended the findings to additional …

… more efficacious than warfarin for the prevention of stroke and systemic embolism in patients
… appear to have a favorable safety profile, making them promising alternatives to warfarin. …